Landini-Enríquez VV, Osorio-Aragón IY, González-González M, Barbosa-Ramírez BM

Language: Spanish
References: 6
Page: 508-509
PDF size: 100.98 Kb.

Text Extraction

No abstract.

REFERENCES

1. Turner S, Lamant L, Kenner L y Brugières L, Anaplastic large cell lymphomain paediatric and young adult patients, British Journal Of Haematology 2016; 173(4):560-2. doi: 10.1111/bjh.13958.

2. Geller S, Canavan T, Pulitzer M, Moskowitz A y Myskowski P, alk-positiveprimary cutaneous anaplastic large cell lymphoma: a case reportand review of the literature, International Journal of Dermatology 2017;57(5):515-20. doi: 10.1111/ijd.13804.

3. Vargas T, Jorge S y Gonzaga Y, cd30-positive cutaneous lymphoma:report of four cases with an emphasis on clinicopathological correlations,Anais Brasileiros de Dermatologia 2017; 92(1):86-91. doi: 10.1590/abd1806-4841.20174807.

4. Vu K y Ai W, Update on the treatment of anaplastic large cell lymphoma,Current Hematologic Malignancy Reports 2018; 13(2):135-41. doi:10.1007/s11899-018-0436-z.

5. Benner MF y Willemze R, Bone marrow examination has limited valuein the staging of patients with an anaplastic large cell lymphoma firstpresenting in the skin: retrospective analysis of 107 patients, Br J Dermatol2008; 159(5):1148-51.

6. Benner M y Willemze R, Applicability and prognostic value of the newtnm classification system in 135 patients with primary cutaneous anaplasticlarge cell lymphoma, Archives of Dermatology 2009; 145(12). doi:10.1001/archdermatol.2009.280.